Your browser doesn't support javascript.
loading
Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study.
Ding, Xiaoyan; Sun, Wei; Li, Wei; Shen, Yanjun; Guo, Xiaodi; Teng, Ying; Liu, Xiaomin; Zheng, Linlin; Li, Wendong; Chen, Jinglong.
Afiliación
  • Ding X; Department of Cancer Center, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Sun W; Department of Cancer Center, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Li W; Department of Cancer Center, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Shen Y; Department of Cancer Center, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Guo X; Department of Cancer Center, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Teng Y; Department of Cancer Center, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Liu X; Department of Cancer Center, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Zheng L; Jinan Eco-environmental Monitoring Center of Shandong Province, Shandong, China.
  • Li W; Department of Cancer Center, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Chen J; Department of Cancer Center, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Cancer ; 127(20): 3782-3793, 2021 10 15.
Article en En | MEDLINE | ID: mdl-34237154

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trombosis / Quimioembolización Terapéutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trombosis / Quimioembolización Terapéutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Año: 2021 Tipo del documento: Article País de afiliación: China